ARCHIVES

New Abiraterone Acetate Results Show Greater Benefit Than Before

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Peter Shields Named Deputy Director At Ohio State

September 16, 2011

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy

November 30, 2012

A Texas Radiation Center’s Survival Move Draws M.D. Anderson Into PPM Competition

February 27, 1998

Men With Low PSA Scores May Not Need Annual Tests, Data From PLCO Trial Suggests

May 31, 2002

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

June 19, 1992